LAW OFFICE OF BRODSKY & SMITH, LLC ANNOUNCES CLASS ACTION AGAINST CURALEAF HOLDINGS, INC. (OTC: CURLF)

BALA CYNWYD, September 3, 2019 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against Curaleaf Holdings, Inc. (“Curaleaf” or the “Company”) (OTC – CURLF – News) for possible breaches of Federal Securities law.

According to the filed complaint, during the class period, Curaleaf Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you purchased shares of Curaleaf between November 21, 2018 and July 22, 2019 and wish to discuss the legal ramifications of  the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. The deadline for filing is October 4, 2019. You may contact Marc Ackerman, Esquire or Jordan Schatz, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, or by calling toll free 877-534-2590.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.